Employer-insured enrollees spend more on prescriptions than health-insurance exchange enrollees, but the groups spend the same amount of money when it comes to specialty medications, a study shows.
HHS says the government and Seattle Seahawks discussed the PSA soon after the 2014 Superbowl win.
Centers for Medicare and Medicaid Services says it is too early to blame a sluggish economy for slow growth.
More cost data for the file the latest data shows that up-front healthcare costs are prompting many patients to delay office visits.
The CBO projected 13 million enrolled in 2015, but its projections were based before final 2014 numbers were in.
Patients will now be able to compare plans and identify ones that have disease-specific programs.
The numbers folks at the Centers for Medicare and Medicaid Services anticipate sluggish growth in US healthcare spend, but prescriptions look ready to take off.
A proposal by the Obama administration Friday seeks to keep contraception accessible and coverage approval at arm's length for employees of religious non-profits.
These healthcare plans allow employees and employers to avoid ACA penalties but provide little coverage.
The cost of fixing healthcare.gov is hovering at around $1 billion, up from the $677-million figure quoted in December
The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.
The Centers for Medicare and Medicaid Services launched a new site Monday to help patients understand how to use their health coverage.
An early look at healthcare reforms impact indicates that allowing children to stay on a parent's healthcare plan until they turned 26 did not translate into higher use of medical care, but did lower out-of-pocket healthcare costs for the 19-25 age group.
The Urban Institute Health Policy Center says putting money behind call centers and person-to-person contact will increase insurance enrollments among Hispanics.
With just days before the enrollment deadline, courts are pulsing with legal opposition to heatlhcare reform insurance subsidies.
The March 31 deadline for health insurance is not the be-all-and-end-all, while a survey found that 50% of the uninsured intend to stay that way.
Around 25% of 18-34 year-olds have signed up for coverage. Obama's FunnyorDie appearance drives HHS traffic.
Hospitals are contemplating financial incentives—as in fines or less support—for patients who could have signed up for health insurance but opted not to.
The program has yet to reach magnet status among cheaper, youthful patients.
HHS has bought airtime in markets with high numbers of uninsured patients.
The White House has until Friday to issue a response to a Supreme Court injunction that temporarily eased birth-control coverage requirements.
Coverage is required, but the new year kicks off with new patients and a lot of loose ends.
A recent government forecast shows the Affordable Care Act is expected to give drugmakers a boost that will grow over time.
The HHS Secretary has some positive enrollment stats to share, but sentiment shows she and Obama need some reputation rehab.
The president says current subscribers will be able to keep their plans.
Site fixes are reported to lag, but CMS plans on inviting consumers to give Healthcare.gov another go.
Official numbers are pending, but Reuters notes enrollment appears to be just 3% of the government's goal.
The Centers for Medicare and Medicaid Services won't say if the change is connected to Healthcare.gov's bumpy launch.
General support for the legislation is up, despite Healthcare.gov woes.
They're not hiding their love or disdain for reform, including one who says the law brings bias into the exam room.
- Sunovion hires former BI exec as VP of marketing
- Five things for pharma marketers to know: Thursday, October 20, 2016
- Five things for pharma marketers to know: Wednesday, October 19, 2016
- Five things for pharma marketers to know: Monday, October 24, 2016
- Five things for pharma marketers to know: Tuesday, October 25, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- Novartis considers new sales model for experimental cancer therapy